BPC-157

BPC‐157 Research Peptide Overview

BPC‐157 (Body Protection Compound‐157) is a synthetic pentadecapeptide fragment derived from a naturally occurring gastric protein complex, investigated for its broad regenerative, angiogenic, and cytoprotective properties in preclinical models.

Molecular Composition and Mechanistic Profile

• Peptide identity: BPC‐157 is a 15–amino acid peptide (pentadecapeptide)

• Origin: Synthetic fragment of “body protection compound” (BPC), originally isolated from human gastric juice.

• Mechanistically, BPC‐157 has been associated with:

• Strong angiogenic activity: stimulation of VEGF/VEGFR2 signaling, increased endothelial cell proliferation, and enhanced “vascular running” (growth of new vessels toward injured areas).

• Modulation of nitric oxide (NO) pathways via the Akt‐eNOS axis, improving blood flow, normalizing coagulation, and protecting vascular endothelium, including prevention and reversal of thrombosis in some animal models.

• Direct effects on fibroblast migration and proliferation—fibroblast migration rates up to ~2.5× and outgrowth ~3× higher than control in vitro—supporting collagen synthesis and tissue remodeling.

• Broad cytoprotective signaling, including ERK1/2 and FAK–paxillin activation, which enhance cell survival, adhesion, and motility at injury sites.

• These overlapping pathways help explain its multi‐tissue regenerative profile in preclinical work.

Integrated Research Applications

• BPC‐157 is studied across numerous tissue systems as a generalized healing and homeostasis modulator. Representative domains include:

• Gastrointestinal and hepatic models: Protection against ulcers, leaky gut, IBS‐like symptoms, Crohn‐type inflammation, and toxic liver injury (e.g., CCl4, NSAID, and alcohol models), with improved mucosal healing and barrier integrity.

• Muscle, tendon, and ligament repair: Accelerated healing of tendon and ligament injuries, improved muscle regeneration, and enhanced biomechanical strength, with higher local levels of growth factors such as VEGF, bFGF, and EGF in healing tissues.

• Bone, joint, and neuromuscular systems: Benefits in bone repair, spinal cord and peripheral nerve injury, and neuromuscular junction stabilization, including anti‐spasticity and improved functional recovery in some animal models.

• Cardiovascular and neurovascular injury: Protection in heart ischemia models, eye injuries, and various CNS insults through combined vascular, anti‐inflammatory, and antioxidative mechanisms.

  Overall, BPC‐157 is used as a tool to explore coordinated healing and homeostasis restoration at the levels of blood vessels, connective tissues, and neural structures.

Analytical Validation, Formulation, and Storage

• Peptide Sciences and similar vendors supply BPC‐157 primarily as a lyophilized peptide (e.g., 5 mg vials and capsule formats), labeled exclusively for research use. Typical quality and handling features include:

• Purity: ≥99% verified by HPLC.

• Formulation: White powder in glass vials or encapsulated; intended to be

  reconstituted with appropriate solvent for experimental use, with no dosing instructions provided for humans or animals.

  Storage recommendations follow standard peptide practice:

  Keep lyophilized peptide in a cool, dark, dry environment; long‐term storage typically at or below −20 °C.

• Store reconstituted solutions refrigerated, avoid repeated freeze–thaw cycles, and use within lab‐defined time windows.

  These conditions support structural stability and reproducible activity across experiments.

NextGenPeps supplies BPC-157 as a high-purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine and canine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.